MedPath

Wetness Sensing System

Not Applicable
Completed
Conditions
System Validation
Interventions
Device: Wetness Sensing System Validation
Registration Number
NCT05454813
Lead Sponsor
Medline Industries
Brief Summary

The investigational product to be evaluated in this study is FitRight® ConnectTM Wetness Sensing System which includes: the FitRight® ConnectTM Pod, the FitRight® ConnectTM App, the FitRight® ConnectTM charger/adapter and the FitRight® ConnectTM Sensing Brief-(Medline Industries, LP) henceforth, referred to as FitRight® System, Pod, App, Charger, Alert Indicator and Brief. The purpose of this study is to validate the FitRight System sensor's ability to detect when an adult brief has absorbed enough liquid (\~90-360 milliliters (mL)) normal saline via simulated urinary void to trigger an alert to change the brief.

Detailed Description

Each participant will be provided with the FitRight® System for the duration of the study. The study products will be used to collect real-life measurement data in order to assess the FitRight® System. Each participant will be asked to wear at least three briefs so that they are wearing each brief during the simulated voids performed by the site staff. The site staff will perform the simulated void by addition of (90-360 mL normal saline to the brief. The FitRight® System will be assessed for alerts while participants are in the following positions: supine, sitting, and laying on either left or right side. Each participant will be randomized to either the left or right side. Twenty-two of the fifty-six participants will perform rewet testing procedures. The study results will be used to assess the reliability of the device's absorption to trigger an alert

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Individuals at least18 years of age
  • Individual can dress and undress self with no assistance
  • Individuals can ambulate without assistance
  • Individual can sit unsupported in a chair or on bedside with no assistance
  • Individual can lay supine and propel self up with no assistance
  • Individual can lie left/right lateral and propel self up with no assistance
  • Individuals who have hip dimensions between 32" and 70" (81-178 cm
Exclusion Criteria
  • Individual is sensitive to the components of the study product(s).
  • Individual is considered inappropriate by the Principal Investigator (PI).
  • Individual has self-reported current skin condition(s) or issues around the sacral or perineal areas, such as open sores, sacral pressure injuries, rash, burns, surgical wounds and/or compromise of skin integrity.
  • Individuals who cannot complete all phases of the study requirements.
  • Individual requires use of an absorbent undergarment or catheter as the primary incontinence management strategy
  • Individuals who are pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AllWetness Sensing System ValidationEach participant will be provided with the FitRight ® System for the duration of the study. The study products will be used to collect real-life measurement data in order to assess the FitRight® System.
Primary Outcome Measures
NameTimeMethod
Sensor Detection5 minutes after each amount (90-360 milliliters) saline is poured into the brief. There could be up to four pours for each brief and 3 briefs (one for each position).

Evaluate the FitRight System sensor's ability to detect when an adult brief has absorbed enough liquid (\~90-360mL) normal saline via a simulated urinary void to trigger an alert to change the brief in the sitting, supine, and right or left side positions.

Secondary Outcome Measures
NameTimeMethod
Rewet Test10 minutes after the 360 milliliters saline is poured into the brief.

Determine the FitRight Brief's residual volume capacity. In a subset of 22 participants, evaluate the FitRight Brief after the brief has absorbed the maximum amount of liquid normal saline via a simulated urinary void (360mL) in the sitting position and then weighed via the rewet procedure.

Trial Locations

Locations (1)

Rochester Clinical Research, Inc.

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath